Price
$0.8
Increased by +33.33%
Dollar Volume
36.42 K
ADR%
22.33
Market Cap.
6.26 M
Shares Float
4.76 M
Shares Outstanding
7.82 M
Beta
0.00
Price / Earnings
-0.11
BPR
11.04
20D Range
0.45 0.85
50D Range
0.38 0.95
200D Range
0.38 4.05
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 14, 22 -0.21 -0.12
Decreased by -75.00%
Aug 15, 22 -0.49 -0.11
Decreased by -345.45%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 18.22 K
Increased by +82.73%
-1.63 M
Decreased by -221.77%
Decreased by -8.96 K%
Decreased by -76.09%
Jun 30, 22 10.68 K - -3.71 M -
Decreased by -34.73 K%
-
Mar 31, 22 9.03 K - -936.09 K -
Decreased by -10.37 K%
-
Dec 31, 21 11.98 K - -3.14 M -
Decreased by -26.19 K%
-
Dec 31, 20 9.97 K - -507.52 K -
Decreased by -5.09 K%
-
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.